Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INTRANASAL IMMUNIZATION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 181 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hansson, M; Samuelson, P; Gunneriusson, E; Stahl, S
      Surface display on gram positive bacteria

      COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    2. Michalek, SM; Katz, J; Childers, NK
      A vaccine against dental caries - An overview

      BIODRUGS
    3. Barackman, JD; Ott, G; Pine, S; O'Hagan, DT
      Oral administration of influenza vaccine in combination with the adjuvantsLT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    4. Brooking, J; Davis, SS; Illum, L
      Transport of nanoparticles across the rat nasal mucosa

      JOURNAL OF DRUG TARGETING
    5. Childers, NK; Powell, WD; Tong, G; Kirk, K; Wiatrak, B; Michalek, SM
      Human salivary immunoglobulin and antigen-specific antibody activity aftertonsillectomy

      ORAL MICROBIOLOGY AND IMMUNOLOGY
    6. Klein, JO; Chonmaitree, T; Loosmore, S; Marchant, CD; Ruuskanen, O; Shinefield, HR
      Otitis media: a preventable disease? Proceedings of an International Symposium organized by the Marcel Merieux Foundation, Veyrier-du-Lac, France, February 13 to 16, 2000

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    7. Le Buanec, H; Vetu, C; Lachgar, A; Benoit, MA; Gillard, J; Paturance, S; Aucouturier, J; Gane, V; Zagury, D; Bizzini, B
      Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes

      BIOMEDICINE & PHARMACOTHERAPY
    8. Russell, MW
      Potential for vaccines in the prevention of caries lesions

      OPERATIVE DENTISTRY
    9. Simmons, CP; Ghaem-Magami, M; Petrovska, L; Lopes, L; Chain, BM; Williams, NA; Dougan, G
      Immunomodulation using bacterialeEnterotoxins

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    10. Singh, M; Vajdy, M; Gardner, J; Briones, M; O'Hagan, D
      Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity

      VACCINE
    11. Coste, A; Cohen, J; Reinhardt, M; Kraehenbuhl, JP; Sirard, JC
      Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 andVP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring

      VACCINE
    12. Brayden, DJ; Templeton, L; McClean, S; Barbour, R; Huang, JP; Nguyen, M; Ahern, D; Motter, R; Johnson-Wood, K; Vasquez, N; Schenk, D; Seubert, P
      Encapsulation in biodegradable microparticles enhances serum antibody response to parenterally-delivered beta-amyloid in mice

      VACCINE
    13. Mantis, NJ; Kozlowski, PA; Mielcarz, DW; Weissenhorn, W; Neutra, MR
      Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies

      VACCINE
    14. Whittum-Hudson, JA; Rudy, D; Gerard, H; Vora, G; Davis, E; Haller, PK; Prattis, SM; Hudson, AP; Saltzman, WM; Stuart, ES
      The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis

      VACCINE
    15. McCluskie, MJ; Weeratna, RD; Clements, JD; Davis, HL
      Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants

      VACCINE
    16. de Haan, L; Verweij, WR; Holtrop, M; Brands, R; van Scharrenburg, GJM; Palache, AM; Agsteribbe, E; Wilschut, J
      Nasal or intramuscular immunization of mice with influenza subunit antigenand the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

      VACCINE
    17. Conacher, M; Alexander, J; Brewer, JM
      Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)

      VACCINE
    18. Pizza, M; Giuliani, MM; Fontana, MR; Monaci, E; Douce, G; Dougan, G; Mills, KHG; Rappuoli, R; Del Giudice, G
      Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants

      VACCINE
    19. Partidos, CD; Beignon, AS; Semetey, V; Briand, JP; Muller, S
      The bare skin and the nose as non-invasive routes for administering peptide vaccines

      VACCINE
    20. Wachsman, M; Kulka, M; Smith, CC; Aurelian, L
      A growth and latency compromised herpes simplex virus type 2 mutant (ICP10Delta PK) has prophylactic and therapeutic protective activity in guinea pigs

      VACCINE
    21. Isaka, M; Yasuda, Y; Mizokami, M; Kozuka, S; Taniguchi, T; Matano, K; Maeyama, J; Mizuno, K; Morokuma, K; Ohkuma, K; Goto, N; Tochikubo, K
      Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

      VACCINE
    22. Woodland, DL; Hogan, RJ; Zhong, WM
      Cellular immunity and memory to respiratory virus infections

      IMMUNOLOGIC RESEARCH
    23. McNeela, EA; Mills, KHG
      Manipulating the immune system: humoral versus cell-mediated immunity

      ADVANCED DRUG DELIVERY REVIEWS
    24. Boyaka, PN; McGhee, JR
      Cytokines as adjuvants for the induction of mucosal immunity

      ADVANCED DRUG DELIVERY REVIEWS
    25. Haneberg, B; Berstad, AKH; Holst, J
      Bacteria-derived particles as adjuvants for non-replicating nasal vaccines

      ADVANCED DRUG DELIVERY REVIEWS
    26. Hu, KF; Lovgren-Bengtsson, K; Morein, B
      Immunostimulating complexes (ISCOMs) for nasal vaccination

      ADVANCED DRUG DELIVERY REVIEWS
    27. Olszewska, W; Steward, MW
      Nasal delivery of epitope based vaccines

      ADVANCED DRUG DELIVERY REVIEWS
    28. Mohamedi, SA; Heath, AW; Jennings, R
      A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2ISCOMs in mice; cytokine profiles, antibody responses and protection

      ANTIVIRAL RESEARCH
    29. Depiero, A; Kaminski, DA; Halsey, JF; Briles, D; Burrows, PD; Hostoffer, RW
      Immunologic compensation in a patient with a large IgH constant region deletion

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    30. Loehr, BI; Rankin, R; Pontarollo, R; King, T; Willson, P; Babiuk, LA; Littel-van den Hurk, SV
      Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle

      VIROLOGY
    31. Simell, B; Korkeila, M; Pursiainen, H; Kilpi, TM; Kayhty, H
      Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin A, pneumolysin, and pneumococcal surface protein A in children

      JOURNAL OF INFECTIOUS DISEASES
    32. Saeland, E; Jakobsen, H; Ingolfsdottir, G; Sigurdardottir, ST; Jonsdottir, I
      Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B

      JOURNAL OF INFECTIOUS DISEASES
    33. Ugozzoli, M; Santos, G; Donnelly, J; O'Hagan, DT
      Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant

      JOURNAL OF INFECTIOUS DISEASES
    34. Staats, HF; Bradney, CP; Gwinn, WM; Jackson, SS; Sempowski, GD; Liao, HX; Letvin, NL; Haynes, BF
      Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization

      JOURNAL OF IMMUNOLOGY
    35. Simmons, CP; Hussell, T; Sparer, T; Walzl, G; Openshaw, P; Dougan, G
      Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8(+) T cell responses

      JOURNAL OF IMMUNOLOGY
    36. Coppens, I; Alonso, S; Antoine, R; Jacob-Dubuisson, F; Renauld-Mongenie, G; Jacobs, E; Locht, C
      Production of Neisseria meningitidis transferrin-binding protein B by recombinant Bordetella pertussis

      INFECTION AND IMMUNITY
    37. Magee, AD; Yother, J
      Requirement for capsule in colonization by Streptococcus pneumoniae

      INFECTION AND IMMUNITY
    38. Huang, Y; Hajishengallis, G; Michalek, SM
      Induction of protective immunity against Streptococcus mutans colonizationafter mucosal immunization with attenuated Salmonella enterica serovar Typhimurium expressing an S-mutans adhesin under the control of in vivo-inducible nirB promoter

      INFECTION AND IMMUNITY
    39. Hodge, LM; Marinaro, M; Jones, HP; McGhee, JR; Kiyono, H; Simecka, JW
      Immunoglobulin A (IgA) responses and IgE-associated inflammation along therespiratory tract after mucosal but not systemic immunization

      INFECTION AND IMMUNITY
    40. Pal, S; Theodor, I; Peterson, EM; De La Maza, LM
      Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge

      INFECTION AND IMMUNITY
    41. Chies, MD; Martensen, PM; Simmons, C; Porakishvili, N; Justesen, J; Dougan, G; Roitt, IM; Delves, PJ; Lund, T
      Refocusing of B-cell responses following a single amino acid substitution in an antigen

      IMMUNOLOGY
    42. Pizza, M; Giuliani, MM; Fontana, MR; Douce, G; Dougan, G; Rappuoli, R
      LTK63 and LTR72, two mucosal adjuvants ready for clinical trials

      INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
    43. Brandt, ER; Sriprakash, KS; Hobb, RI; Hayman, WA; Zeng, WG; Batzloff, MR; Jackson, DC; Good, MF
      New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population

      NATURE MEDICINE
    44. Mestecky, J; Russell, MW
      Induction of mucosal immune responses in the human genital tract

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    45. Suckow, MA; Park, K; Siger, L; Turek, J; Borie, D; Van Horn, D; Taylor, A; Park, H; Bowersock, TL
      Immunogenicity of antigens in boiled alginate microspheres

      JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
    46. Eskola, J; Kilpi, T
      Potential of bacterial vaccines in the prevention of acute otitis media

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    47. Hamajima, K; Xin, KQ; Fukushima, J; Yang, J; Honsho, A; Nakazawa, M; Yanoma, S; Okuda, K
      HIV-DNA vaccination following transfer of a large number of activated T cells enhances immunoresponses against HIV-1

      VIRAL IMMUNOLOGY
    48. Nally, JE; Artiushin, S; Sheoran, AS; Burns, PJ; Simon, B; Gilley, RM; Gibson, J; Sullivan, S; Timoney, JF
      Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system

      VACCINE
    49. Kunisawa, J; Okudaira, A; Tsutusmi, Y; Takahashi, I; Nakanishi, T; Kiyono, H; Mayumi, T
      Characterization of mucoadhesive microspheres for the induction of mucosaland systemic immune responses

      VACCINE
    50. Hilgers, LAT; Ghenne, L; Nicolas, I; Fochesato, M; Lejeune, G; Boon, B
      Alkyl-polyacrylate esters are strong mucosal adjuvants

      VACCINE
    51. Tebbey, PW; Scheuer, CA; Peek, JA; Zhu, DZ; LaPierre, NA; Green, BA; Phillips, ED; Ibraghimov, AR; Eldridge, JH; Hancock, GE
      Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H

      VACCINE
    52. Enioutina, EY; Visic, D; Daynes, RA
      The induction of systemic and mucosal immune responses to antigen-adjuvantcompositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity

      VACCINE
    53. Berstad, AKH; Andersen, SR; Dalseg, R; Dromtorp, S; Holst, J; Namork, E; Wedege, E; Haneberg, B
      Inactivated meningococci and pertussis bacteria are immunogenic and act asmucosal adjuvants for a nasal inactivated influenza virus vaccine

      VACCINE
    54. Kozuka, S; Yasuda, Y; Isaka, M; Masaki, N; Taniguchi, T; Matano, K; Moriyama, A; Ohkuma, K; Goto, N; Udaka, S; Tochikubo, K
      Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity

      VACCINE
    55. Muszkat, M; Friedman, G; Schein, MH; Naveh, P; Greenbaum, E; Schlesinger, M; Zakay-Rones, Z; Ben Yehuda, A
      Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly

      VACCINE
    56. Bernstein, DI
      Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection

      VACCINE
    57. Kato, H; Bukawa, H; Hagiwara, E; Xin, KQ; Hamajima, K; Kawamoto, S; Sugiyama, M; Sugiyama, M; Noda, E; Nishizaki, M; Okuda, K
      Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses

      VACCINE
    58. Marinova, S; Tchorbadjiiska, L; Petrunov, B; Cvetanov, J; Nenkov, P; Konstantinova, D; Markova, R
      Immunostimulating and protective effects of an oral polybacterial immunomodulator 'Dentavax' in a rabbit experimental model

      INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY
    59. Chen, HM
      Recent advances in mucosal vaccine development

      JOURNAL OF CONTROLLED RELEASE
    60. Eyles, JE; Williamson, ED; Spiers, ID; Stagg, AJ; Jones, SM; Alpar, HO
      Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits

      JOURNAL OF CONTROLLED RELEASE
    61. Cheng, H; Tumpey, TM; Staats, HF; van Rooijen, N; Oakes, JE; Lausch, RN
      Role of macrophages in restricting herpes simplex virus type 1 growth alter ocular infection

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    62. Delves, PJ; Roitt, IM
      Advances in immunology: The immune system - Second of two parts.

      NEW ENGLAND JOURNAL OF MEDICINE
    63. Loehr, BI; Willson, P; Babiuk, LA; Littel-van den Hurk, SV
      Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle

      JOURNAL OF VIROLOGY
    64. Orson, FM; Kinsey, BM; Hua, PJ; Bhogal, BS; Densmore, CL; Barry, MA
      Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses

      JOURNAL OF IMMUNOLOGY
    65. Weltzin, R; Guy, B; Thomas, WD; Giannasca, PJ; Monath, TP
      Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection

      INFECTION AND IMMUNITY
    66. Ricci, S; Medaglini, D; Rush, CM; Marcello, A; Peppoloni, S; Manganelli, R; Palu, G; Pozzi, G
      Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii

      INFECTION AND IMMUNITY
    67. Childers, NK; Miller, KL; Tong, G; Llarena, JC; Greenway, T; Ulrich, JT; Michalek, SM
      Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen

      INFECTION AND IMMUNITY
    68. Wu, HY; Abdu, S; Stinson, D; Russell, MW
      Generation of female genital tract antibody responses by local or central (common) mucosal immunization

      INFECTION AND IMMUNITY
    69. Shen, XZ; Lagergard, T; Yang, YH; Lindblad, M; Fredriksson, M; Holmgren, J
      Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera term B subunit conjugate vaccine

      INFECTION AND IMMUNITY
    70. Bacon, A; Makin, J; Sizer, PJ; Jabbal-Gill, I; Hinchcliffe, M; Illum, L; Chatfield, S; Roberts, M
      Carbohydrate biopolymers enhance antibody responses to mucosally deliveredvaccine antigens

      INFECTION AND IMMUNITY
    71. Martin, M; Metzger, DJ; Michalek, SM; Connell, TD; Russell, MW
      Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb

      INFECTION AND IMMUNITY
    72. Neidleman, JA; Vajdy, M; Ugozzoli, M; Ott, G; O'Hagan, D
      Genetically detoxified mutants of heat-labile enterotoxin from Escherichiacoli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55

      IMMUNOLOGY
    73. Jenkins, PG
      Mucosal vaccine delivery

      EXPERT OPINION ON THERAPEUTIC PATENTS
    74. Baca-Estrada, ME; Foldvari, M; Snider, M
      Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    75. Russell, MW; Hedges, SR; Wu, HY; Hook, EW; Mestecky, J
      Mucosal immunity in the genital tract: Prospects for vaccines against sexually transmitted diseases - A review

      AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    76. Piatti, G
      Identification of immunodominant epitopes in the filamentous hemagglutininof Bordetella pertussis

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    77. Abusugra, I; Morein, B
      Iscom is an efficient mucosal delivery system for Mycoplasma mycoides subsp. mycoides (MmmSC) antigens inducing high mucosal and systemic antibody responses

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    78. Lemoine, D; Deschuyteneer, M; Hogge, F; Preat, V
      Intranasal immunization against influenza virus using polymeric particles

      JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
    79. Dale, JB
      Group A streptococcal vaccines

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    80. Moldoveanu, Z; Vzorov, AN; Huang, WQ; Mestecky, J; Compans, RW
      Induction of immune responses to SIV antigens by mucosally administered vaccines

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    81. Lian, TS; Bui, T; Ho, RJY
      Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses

      VACCINE
    82. Isaka, M; Yasuda, Y; Kozuka, S; Taniguchi, T; Matano, K; Maeyama, J; Komiya, T; Ohkuma, K; Goto, N; Tochikubo, K
      Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toroid together with recombinant cholera toxin B subunit as an adjuvant

      VACCINE
    83. Jabbal-Gill, I; Lin, W; Jenkins, P; Watts, P; Jimenez, M; Illum, L; Davis, SS; Wood, JM; Major, D; Minor, PD; Li, XW; Lavelle, EC; Coombes, AGA
      Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines

      VACCINE
    84. Hilbert, AK; Fritzsche, U; Kissel, T
      Biodegradable microspheres containing influenza A vaccine: Immune responsein mice

      VACCINE
    85. Babai, I; Samira, S; Barenholz, Y; Zakay-Rones, Z; Kedar, E
      A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice

      VACCINE
    86. Bastien, N; Trudel, M; Simard, C
      Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines

      VACCINE
    87. Enioutina, EY; Visic, D; McGee, ZA; Daynes, RA
      The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant

      VACCINE
    88. Ishizaka, ST; Israel, ZR; Gettie, A; Mishkin, EM; Staas, JK; Gilley, RM; Dailey, PJ; Montefiori, DC; Marx, PA; Eldridge, JH
      Induction of mucosal antibody responses by microsphere-encapsulated formalin-inactivated simian immunodeficiency virus in a male urethral challenge model

      VACCINE
    89. Xiang, ZQ; Ertl, HCJ
      Induction of mucosal immunity with a replication-defective adenoviral recombinant

      VACCINE
    90. Schroder, U; Svenson, SB
      Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvants

      VACCINE
    91. O'Dowd, AM; Botting, CH; Precious, B; Shawcross, R; Randall, RE
      Novel modifications to the C-terminus of LTB that facilitate site-directedchemical coupling of antigens and the development of LTB as a carrier for mucosal vaccines

      VACCINE
    92. Brandt, ER; Good, MF
      Vaccine strategies to prevent rheumatic fever

      IMMUNOLOGIC RESEARCH
    93. Partidos, CD; Vohra, P; Jones, DH; Farrar, G; Steward, MW
      Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles

      JOURNAL OF CONTROLLED RELEASE
    94. Williams, NA; Hirst, TR; Nashar, TO
      Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

      IMMUNOLOGY TODAY
    95. Partidos, CD; Salani, BF; Pizza, M; Rappuoli, R
      Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides

      IMMUNOLOGY LETTERS
    96. Zinckgraf, JW; Winchell, JM; Silbart, LK
      Antibody responses to a mucosally delivered HIV-1 gp120-derived C4/V3 peptide

      JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    97. Okano, M; Nishizaki, K; Abe, M; Wang, MM; Yoshino, T; Satoskar, AR; Masuda, Y; Harn, DA
      Strain-dependent induction of allergic rhinitis without adjuvant in mice

      ALLERGY
    98. Ramsay, AJ; Kent, SJ; Strugnell, RA; Suhrbier, A; Thomson, SA; Ramshaw, IA
      Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity

      IMMUNOLOGICAL REVIEWS
    99. Freytag, LC; Clements, JD
      Bacterial toxins as mucosal adjuvants

      DEFENSE OF MUCOSAL SURFACES: PATHOGENESIS, IMMUNITY AND VACCINES
    100. Cardenas-Freytag, L; Cheng, L; Mirza, A
      New approaches to mucosal immunization

      MECHANISMS IN THE PATHOGENESIS OF ENTERIC DISEASES 2


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 00:08:44